v3.22.2.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss)/Income
Common Stock (Class A)
Common Stock (Class A)
Common Stock
Common Stock (Class B)
Common Stock
Beginning balance (in shares) at Jan. 30, 2021             22,477,000 7,306,000
Beginning balance at Jan. 30, 2021 $ 160,622 $ 30 $ 155,437 $ 5,135 $ 20      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 52,191     52,191        
Cash dividend (in dollars per share) $ 1.00              
Restricted stock (in shares)   20,000            
Dividends paid ($1.00 per share) $ 30,710     30,710        
Share-based compensation expense 1,417   1,417          
Employee exercises of stock options (in shares)             1,161,000  
Employee stock option exercises 9,130 $ 1 9,129          
Net change in unrealized gain on available-for-sale securities (12)       (12)      
Ending balance (in shares) at Oct. 30, 2021             23,658,000 7,306,000
Ending balance at Oct. 30, 2021 192,638 31 165,983 26,616 8      
Beginning balance (in shares) at Jul. 31, 2021             23,651,000 7,306,000
Beginning balance at Jul. 31, 2021 171,232 31 165,407 5,782 12      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 20,834     20,834        
Share-based compensation expense 521   521          
Employee exercises of stock options (in shares)             7,000  
Employee stock option exercises 55   55          
Net change in unrealized gain on available-for-sale securities (4)       (4)      
Ending balance (in shares) at Oct. 30, 2021             23,658,000 7,306,000
Ending balance at Oct. 30, 2021 192,638 31 165,983 26,616 8      
Beginning balance (in shares) at Jan. 29, 2022             23,719,000 7,306,000
Beginning balance at Jan. 29, 2022 174,713 31 166,929 7,754 (1)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 9,781     9,781        
Restricted stock (in shares)             63,000  
Share-based compensation expense $ 1,764   1,764          
Employee exercises of stock options (in shares) 13,500           13,000  
Employee stock option exercises $ 56   56          
Repurchase of common stock (in shares)           (1,258,330) (1,258,000)  
Repurchase of common stock (10,902) (1)   (10,901)   $ (10,900)    
Net change in unrealized gain on available-for-sale securities 120       120      
Ending balance (in shares) at Oct. 29, 2022             22,537,000 7,306,000
Ending balance at Oct. 29, 2022 175,532 30 168,749 6,634 119      
Beginning balance (in shares) at Jul. 30, 2022             22,805,000 7,306,000
Beginning balance at Jul. 30, 2022 171,568 30 168,120 3,372 46      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 5,149     5,149        
Share-based compensation expense 613   613          
Employee exercises of stock options (in shares)             3,000  
Employee stock option exercises 16 0 16          
Repurchase of common stock (in shares)             (271,000)  
Repurchase of common stock (1,887)     (1,887)        
Net change in unrealized gain on available-for-sale securities 73       73      
Ending balance (in shares) at Oct. 29, 2022             22,537,000 7,306,000
Ending balance at Oct. 29, 2022 $ 175,532 $ 30 $ 168,749 $ 6,634 $ 119